AlphaYouBJ
Insider buying
Benjamin J. Zeskind bought $11K of Immuneering Corp (IMRX) stock
Benjamin J. Zeskind, President And CEO of Immuneering Corp (IMRX), bought 2,400 shares of IMRX stock worth $11K, per an SEC Form 4 filed Jun 24, 2026.
It was an open-market purchase.
The trade happened on Jun 23, 2026, 1 day before it was made public.
IMRX has moved -13.2% since the trade date, from $4.54 to $3.94 (Oct 9, 2026 close).
- Traded
- Jun 23, 2026
- Disclosed
- Jun 24, 2026
- Filing delay
- 1 day
- Price since
- -13.2%
- Role
- President And CEO
- Source
- SEC Form 4
More IMRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.